Skip to main content
. 2018 Jul 23;8:11088. doi: 10.1038/s41598-018-29445-z

Figure 4.

Figure 4

Comparison of GCA and TCDCA composition ratio in patients with benign biliary disease, pancreatic cancer and cholangiocarcinoma.

HHS Vulnerability Disclosure